SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery platform, announced today that Patrick Gan was elected as the Company’s eighth director at Inovio’s annual general meeting. He joins re-elected directors James L. Heppell, chairman of the board, Dr. Avtar Dhillon, president and CEO, and Riaz Bandali, Simon X. Benito, Tazdin Esmail, Robert W. Rieder and Stephen Rietiker, MD.
